Masakuni Horiguchi - Concepedia

Author

Masakuni Horiguchi

Sumitomo Dainippon Pharma (Japan)

Also Known As

Masakuni Horiguchi

Publications

869

Citations

H-Index

Concepts

All Affiliations

Sumitomo Dainippon Pharma (Japan)Northwestern University Vanderbilt University Medical Center Vanderbilt University The University of Tokyo

About

Masakuni Horiguchi is an author at Sumitomo Dainippon Pharma (Japan) specializing in medicine, pharmacology, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	369
2	Social Sciences	7	7	287
3	Natural Sciences	3	3	82
4	Biochemistry	3	3	82
5	Chemical Biology	2	2	59

Masakuni Horiguchi

Publications

634

Citations

H-Index

Page 1

	Year	Citations
Different Functional Aspects of the Group II Subfamily (Types IIA and V) and Type X Secretory Phospholipase A2s in Regulating Arachidonic Acid Release and Prostaglandin Generation Makoto Murakami, Terumi Kambe, Satoko Shimbara, Journal of Biological Chemistry	1999	156
pH‐dependent translocation of α‐tocopherol transfer protein (α‐TTP) between hepatic cytosol and late endosomes Masakuni Horiguchi, Makoto Arita, Daisy E. Kaempf‐Rotzoll, Genes to Cells	2003	72
Interaction of mGlu2/3 agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated rats Masakuni Horiguchi, Mei Huang, Herbert Y. Meltzer Psychopharmacology Mglu2/3 AgonismNeuropsychologyPsychoactive DrugPsychiatryBehavioral Neuroscience	2011	60
The role of 5-HT7 receptor antagonism in the amelioration of MK-801-induced learning and memory deficits by the novel atypical antipsychotic drug lurasidone Tomoko Horisawa, Hiroyuki Nishikawa, Satoko Toma, Behavioural Brain Research Memory DeficitsPsychiatryMedicine5-Ht7 Receptor AntagonismPsychopharmacology	2013	53
5-HT1A and 5-HT7 receptors contribute to lurasidone-induced dopamine efflux Mei Huang, Masakuni Horiguchi, Anna R. Felix, Neuroreport NeuropsychologyPrefrontal CortexPsychopharmacologySocial SciencesMolecular Pharmacology	2012	45
Prevention of the Phencyclidine-Induced Impairment in Novel Object Recognition in Female Rats by Co-Administration of Lurasidone or Tandospirone, a 5-HT1A Partial Agonist Masakuni Horiguchi, Kayleen E. Hannaway, Adesewa E Adelekun, Neuropsychopharmacology Psychoactive DrugBehavioral NeuroscienceMedicinePsychopharmacologyNeuropharmacology	2012	44
D1 receptor agonists reverse the subchronic phencyclidine (PCP)-induced novel object recognition (NOR) deficit in female rats Masakuni Horiguchi, Kayleen E. Hannaway, Adesewa E Adelekun, Behavioural Brain Research Cognitive ScienceNeuropsychologyCognitive NeuroscienceBehavioral NeuroscienceD1 Receptor Agonists	2012	40
Discovery of 3H-imidazo[4,5-c]quinolin-4(5H)-ones as potent and selective dipeptidyl peptidase IV (DPP-4) inhibitors Yohei Ikuma, Hitoshi Hochigai, Hidenori Kimura, Bioorganic & Medicinal Chemistry Medicinal ChemistryBiochemistryAntiparasitic AgentNatural SciencesMedicine	2012	39
The Novel Antipsychotic Drug Lurasidone Enhances N-Methyl-d-aspartate Receptor-Mediated Synaptic Responses Eunice Y. Yuen, Xiangning Li, Wei Jing, Molecular Pharmacology	2011	37
Combined serotonin (5-HT)1A agonism, 5-HT2A and dopamine D2 receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats Yoshihiro Oyamada, Masakuni Horiguchi, Lakshmi Rajagopal, Behavioural Brain Research NeuropsychologyCognitive SciencePsychoactive DrugPsychiatryBehavioral Neuroscience	2014	28

Page 1